New catheter coating to improve dialysis clearance
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new type of hemodialysis catheter (a tube for cleaning your blood) that has a special coating to reduce clotting and blockages. It compares how well this new catheter works compared to similar catheters used in the past.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You agree to take part in the study by signing a consent form.
- You need hemodialysis using a tunneled dialysis catheter (a soft tube placed in a large vein for long-term dialysis).
- You do not have a serious infection that is not controlled (no positive blood culture or high CRP level in the last week).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using special caps with chlorhexidine on dialysis catheters can help prevent serious bloodstream infections. If you have kidney failure and use a tunneled central line for dialysis, this study may be an option for you.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This study tests whether adding a special filter (hemoperfusion) to your regular hemodialysis can better remove waste products that build up in the blood. It might help people on dialysis feel better and have fewer complications.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This study tests a new way to do hemodialysis that might remove certain waste products (called protein-bound uremic toxins) more effectively than standard dialysis. It could help people on long-term dialysis feel better and have fewer complications.
This trial tests a new way to reopen blocked or narrowed fistulas (the blood vessels used for dialysis) in people on hemodialysis. The goal is to see how well it works and if it saves money compared to other treatments.
Hear when a new Haemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.